Scout | Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed)

This grant provides funding for projects that aim to create and use new models, tests, tools, or platforms to improve drug discovery for specific antibiotic-resistant bacteria, including carbapenem-resistant Acinetobacter, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa.

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $750,000

Funding Amount: $750,000

Dates

Opportunity Released: April 1, 2024

Open for Submission: April 1, 2024

Submission Deadline: August 20, 2024

Application Window Closes: August 20, 2024

Keywords

Antibiotic Resistance

Gram-Negative Bacteria

Therapeutic Discovery

Predictive Models

Carbapenem-resistant

Assays Development

Efflux Mechanisms

Acinetobacter

Enterobacteriaceae

Pseudomonas aeruginosa

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers